Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Posaconazole PK in acute leukemia
NCT00936117Phase 2Completed
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- Sep 2009
- Primary completion
- Sep 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of posaconazole in fungal infection, sponsored by University of Texas MD Anderson Cancer Center. Started Sep 2009; status: completed.
02
Drugs
posaconazole
03
Conditions
fungal infection
Beyond the preview
Go deeper on NCT00936117.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00936117.